ENNIS v. SECRETARY OF HEALTH AND HUMAN SERVICES

CourtUnited States Court of Federal Claims
DecidedMay 6, 2026
Docket16-1148V
StatusPublished

This text of ENNIS v. SECRETARY OF HEALTH AND HUMAN SERVICES (ENNIS v. SECRETARY OF HEALTH AND HUMAN SERVICES) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
ENNIS v. SECRETARY OF HEALTH AND HUMAN SERVICES, (uscfc 2026).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS

********************* TERI ENNIS and JOSHUA ENNIS, * on behalf of B.E., minor child, * No. 16-1148V * Petitioners, * Special Master Christian J. Moran * v. * * Filed: April 13, 2026 SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * *********************

Amber Diane Wilson, Wilson Science Law, Washington, DC, and Jennifer Maglio, MCTLAW, Sarasota, FL, for Petitioners; Eleanor A. Hanson, United States Dep’t of Justice, Washington, DC, for Respondent.

PUBLISHED DECISION ON REMAND AWARDING ATTORNEYS’ FEES AND COSTS 1

After the entitlement phase of this case ended via a decision adopting a stipulation awarding Teri and Joshua Ennis $35,000.00 plus an additional $492.00 for a Medicaid lien, the Ennises requested attorneys’ fees and costs, totaling $315,214.40. The Ennises were awarded $272,876.90, which is approximately 86 percent of the amount requested.

Dissatisfied with the reductions made for two experts whom they retained, Thomas Cupps and Omid Akbari, the Ennises challenged the deductions by filing a motion for review. While the case was on review, the Ennises sought additional fees and costs for litigating the fee

1 Because this published decision contains a reasoned explanation for the action in this case, the undersigned is required to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This posting means the decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), the parties have 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. request. The Court granted the motion for review, vacated the underlying decision, and remanded for additional analysis. 2

As to the original fee request, the Ennises are awarded $269,064.40, which is approximately 85 percent of the original amount requested. The supplemental fee request is deferred.

I. Procedural History

A. Entitlement Phase

The Ennises alleged that that the influenza and measles, mumps, rubella vaccines (collectively “the vaccines”) their daughter, B.E., received on February 13, 2015, caused B.E. to suffer from psoriasis and autoimmune hepatitis. Pet., filed Sep. 15, 2016. The Ennises were represented by Attorney Amber Wilson, who was then affiliated with the law firm, Maglio, Christopher & Toale, P.C. 3

The litigation lasted more than eight years. Throughout the entitlement phase of the case, Attorney Colleen Hartley represented the Secretary. Relatively early, the Secretary recommended against an award of compensation because, in part, the Ennises had not presented a report from an expert. Resp’t’s Rep., filed Jan. 19, 2017. Thus, in anticipation of the parties retaining experts, a set of instructions for experts was issued in draft form on July 31, 2017. After the parties did not interpose any objections, the Expert Instructions became final on August 16, 2017.

The Expert Instructions provide guidance about the minimum topics about which the experts should express opinions. One of the introductory parts requires experts to disclose what material they have reviewed. (This portion of the instructions is an attempt to follow the provisions of Rule 26(a)(2)(B)(ii) of the Rules of the Court of Federal Claims, which provides that an expert’s report must contain “the facts or data considered by the witness”). The Expert Instructions state: “The report should identify all background information that the expert has considered.” Expert Instructions ¶ 2.a. The Expert Instructions also provide guidance to the

2 Three separate transcripts are referenced in this decision: the October 14, 2025 transcript from oral argument at the Court of Federal Claims (Ct. Oral Arg. Tr.), the transcript of the January 13, 2026 bench ruling at the Court of Federal Claims (Bench Ruling Tr.), and the transcript from the March 4, 2026 oral argument on remand at the Office of Special Masters (Remand Oral Arg. Tr.). 3 During the litigation, Ms. Wilson stopped working for Maglio, Christopher & Toale and began to work at her own law firm. When it appeared that the case was going to proceed to a hearing, Ms. Wilson added another attorney to assist her with trial. However, the work of the attorneys is not relevant to determining the issues that the Court remanded, which are the reasonableness of fees associated with the experts.

2 experts whom petitioners retain for preparing their invoices. 4 The Expert Instructions directed that “The expert should list separate tasks separately. A rule of thumb is that every half hour should have a separate task, differentiated from other tasks.” Expert Instructions at 8.

To assist them in their claim, The Ennises retained three people: Thomas Cupps, Omid Akbari, and Nanette Silverberg. Of this group, the reasonableness of costs associated with Dr. Cupps and Dr. Akbari remains unresolved.

Dr. Cupps was the first person whom the Ennises retained. He graduated from medical school in 1975. 5 He became board-certified in internal medicine in 1978 and in allergy and immunology in 1982. Beginning in 1983, Dr. Cupps taught within the division of rheumatology, immunology, and allergy at Georgetown University Medical Center. Dr. Cupps held different positions, achieving a full professorship in 2014. He lists four areas of interest for his research: (1) “evaluating the basic immunopathologic mechanisms” for “Wegener’s granulomatosis, systemic necrotizing vasculitis, [and] immune-mediated tissue injury of the [the] skin and subcutaneous tissues,” (2) “central nervous system immune mediated injury including CNS vasculitis,” (3) “sensory hearing loss,” and (4) “Management of immunosuppressive agents.” He also practiced medicine in the same location.

His curriculum vitae lists 86 articles published in peer-reviewed journals with an additional 40 abstracts. The most recent article was published in 2012, which was approximately five years before Dr. Cupps wrote a report for this litigation. Within Dr. Cupps’s list of articles, no articles contain the term “psoriasis” in their titles. Two articles (#33 from 1988 and #54 from 1991) are titled “Dermatomyositis and polymyositis.” Otherwise, no other articles contain the term “dermat-”. Dr. Cupps has several publications about the hepatitis B surface antigen, which is a component of the hepatitis B vaccine. However, none of the articles have titles suggesting publication on autoimmune hepatitis.

Dr. Cupps wrote one report, which is Exhibit 34. The substance of the report is found in approximately 23 single-spaced pages with an additional two pages for references. Dr. Cupps began his report by setting forth his qualifications and identifying some of the materials he reviewed. These two sections take two pages. Although the Expert Instructions require experts to disclose “all” the material reviewed, Dr. Cupps did not disclose everything in his expert report that he listed on his invoice, which was provided much later. In his invoice, Dr. Cupps charged time for “review of letter dated 10-17-17,” and “review of counsel prepared time line.” In addition, although the Expert Instructions seek information about the expert’s experience in treating patients with relevant diseases (here, psoriasis or autoimmune hepatitis) within the last five years (paragraph 1.c), Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Blum v. Stenson
465 U.S. 886 (Supreme Court, 1984)
Avera v. Secretary of Health and Human Services
515 F.3d 1343 (Federal Circuit, 2008)
Fox v. Vice
131 S. Ct. 2205 (Supreme Court, 2011)
Larry Raney v. Federal Bureau of Prisons
222 F.3d 927 (Federal Circuit, 2000)
Locane v. Secretary of Health & Human Services
685 F.3d 1375 (Federal Circuit, 2012)
Biery v. United States
818 F.3d 704 (Federal Circuit, 2016)
Avera v. Secretary of Health & Human Services
75 Fed. Cl. 400 (Federal Claims, 2007)
Locane v. Secretary of Health & Human Services
99 Fed. Cl. 715 (Federal Claims, 2011)
Giles Industries, Inc. v. United States
650 F.2d 274 (Court of Claims, 1981)

Cite This Page — Counsel Stack

Bluebook (online)
ENNIS v. SECRETARY OF HEALTH AND HUMAN SERVICES, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ennis-v-secretary-of-health-and-human-services-uscfc-2026.